Wednesday, 30 September 2026Updated 12m ago
← Top stories
● Neutral for Indian equities

Lilly’s experimental drug cuts weight by 21% in a diabetes trial

2 sources · first seen 03:45 30 Sept · updated 20:02 30 Sept

The brief

Written from 2 reports · check the source before you trade
  • Lilly’s experimental drug cut weight by 21% in a diabetes trial
  • Adding Lilly’s drug to Zepbound helped people lose up to 23%, with more side effects

Tags on this story

Pick a tag to see all its stories
Eli Lilly2 todayPharma and healthcare32 today

Linked by the tag Eli Lilly

11 stories this week
  1. 28 SeptKerala HC says government can intervene over exorbitant prices of patented drugsLegal · 3 sources · The Kerala High Court ruled government intervention is permissible for prohibitively priced patented medicines
All Eli Lilly stories →

Read the reports

2 reports · earliest 03:45
ReutersLilly's experimental drug cuts weight by 21% in diabetes trial03:45MarketWatchAdding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.20:02